close video
Get flash to see this player
insider - College of Medicine News Resource - University of Florida

UF diabetes researcher gets grant to fast-track discoveries

Share:
  • email
  • Facebook
  • Digg
  • Twitter
By Melanie Ross
Published: September 1st, 2008 • Category: Awards, Faculty Recognition, Faculty in the News, Pathology, Immunology, and Laboratory Medicine

Dr. Chang-Qing Xia, from the College of Medicine department of pathology, immunology and laboratory medicine.

University of Florida research assistant professor Dr. Chang-Qing Xia, from the College of Medicine department of pathology, immunology and laboratory medicine, has received a two-year $570,000 grant from the Juvenile Diabetes Research Foundation.

The funds are part of a JDRF program designed to fast-track scientific discoveries. Xia will partner with industry to test a diabetes prevention therapy and move it rapidly into clinical testing in people if preliminary findings prove promising.

Xia will test an approach designed to lessen the immune system’s attack on insulin-producing cells in the pancreas. Called extracorporeal photopheresis therapy, the procedure isolates white blood cells from a blood sample and primes them with a light-activated drug. The cells are then treated with ultraviolet light and reinfused.

The study will be conducted in collaboration with Therakos, a division of Johnson & Johnson that manufactures the equipment used to isolate the blood cells.

Related Articles:

  • UF shines blue for diabetes During November, the University of Florida will shine a “blue” spotlight on diabetes with several events planned to raise awareness and promote prevention of the disease....
  • UF researcher to probe evolution of HIV-related dementia Marco Salemi, Ph.D., an assistant professor in the department of pathology, immunology and laboratory medicine at the UF College of Medicine, has won a five-year, $3.5 million NIH grant to...
  • AIDS researcher to study development of HIV vaccine College of Medicine AIDS researcher, Maureeen Goodenow, Ph.D., to take part in a federal program sponsored by the National Institute of Allergy and Infectious Diseases to study HIV vaccine research....